Convergence Investment Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
WRF
MCMC
Convergence Investment Partners's CDNA Position: Q1 2021 in Review
Convergence Investment Partners sold out of CareDx (CDNA) in Q1 2021, closing a stake of 2,577 shares — an estimated $187K sold.
Convergence Investment Partners first reported a position in CDNA in Q4 2020 and held it in 1 quarter. The position peaked at $187K in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.
- Convergence Investment Partners reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
- Convergence Investment Partners sold 2,577 CareDx shares in Q1 2021, an estimated $187K.
- Convergence Investment Partners first reported a position in CareDx in Q4 2020 and held it in 1 quarter.
- Convergence Investment Partners's CareDx position peaked at $187K in Q4 2020.
- 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.
Based on Convergence Investment Partners's 13F filing for Q1 2021, filed 30 Apr 2021.